Christopher M. Starr, Director at Raptor Pharmaceutical Corp (RPTP), sold 20,033 shares at $11.62 ($233K) on 2015-03-23, disclosed to the SEC on 2015-03-25.
Scheduled sale ($233k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RPTP | SELL | 2015-02-25 | $286K | — | Filing → |
| RPTP | SELL | 2015-02-19 | $281K | — | Filing → |
| RPTP | SELL | 2015-01-26 | $284K | — | Filing → |